Azitra Inc (AZTR)

$0.14 +0.00 (2.94%)
Market Cap 8.05M
Revenue (ttm) 0.00
Net Income (ttm) -10.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 721,102
Avg Vol 14,696,055
Day's Range N/A - N/A
Shares Out 60.60M
Stochastic %K 35%
Beta -1.19
Analysts Strong Sell
Price Target $0.78

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically m...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 646 6446
Address:
21 Business Park Drive, Branford, United States
cheapostock
cheapostock Aug. 21 at 4:42 PM
next week watchlist, boring friday but fishing needs patience!!! $PFSA $ELAB $AZTR $LIMN $VBIO 🫡
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 21 at 12:04 PM
$AZTR Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
0 · Reply
TheOne_24
TheOne_24 Aug. 21 at 6:05 AM
$AZTR $AIM $YYAI $CXAI $SMTK AZTR 🚀 BULLISH THESIS Biotech + AI-driven discovery + precision dermatology/cosmetics. Multiple catalysts across ATR-04, ATR-12, ATR-01 & ATR-COSF, including clinical data and human-skin results. 💥 AI + peptide/protein platform + multiple shots on goal = high-upside catalyst setup. 🔥 High risk microcap, but the pipeline + AI angle make AZTR one to watch.
0 · Reply
PURPLEBOY44
PURPLEBOY44 Aug. 19 at 7:57 PM
$AZTR i’ve been around for a little bit +20 years trading this little company might become a buyout candidate. I’m basing it on the news that Moderna just put out. Just my opinion though. Be careful with this one, but I got a feeling. 
0 · Reply
cheapostock
cheapostock Aug. 19 at 2:39 PM
$PFSA $LIMN $AZTR
0 · Reply
cheapostock
cheapostock Aug. 19 at 2:38 PM
$PFSA congrats to bull... move your profit to $AZTR
0 · Reply
cheapostock
cheapostock Aug. 19 at 1:29 PM
$AZTR add low and slow on this....
0 · Reply
cheapostock
cheapostock Aug. 18 at 7:56 PM
$AZTR seems real
0 · Reply
Omarzaid
Omarzaid Aug. 13 at 12:42 AM
$AZTR https://ir.azitrainc.com/news-releases/news-release-details/azitra-inc-announces-q2-2026-results-and-provides-business
0 · Reply
HumblKing
HumblKing Aug. 11 at 8:07 PM
$AZTR patent news
0 · Reply
Latest News on AZTR
Azitra regains NYSE American compliance

2026-08-21T12:05:30.000Z - 3 days ago

Azitra regains NYSE American compliance

Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards

Aug 21, 2026, 8:00 AM EDT - 3 days ago

Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards

Azitra reports Q2 EPS (17c) vs. ($1.18) last year

2026-08-17T08:41:50.000Z - 7 days ago

Azitra reports Q2 EPS (17c) vs. ($1.18) last year

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates

Aug 12, 2026, 5:00 PM EDT - 11 days ago

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates

Azitra Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 12 days ago

Azitra Quarterly report: Q2 2026

Azitra Earnings release: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 12 days ago

Azitra Earnings release: Q2 2026

Meet Azitra: Fly Exclusive with CEO Francisco Salva

2026-07-29T18:10:35.000Z - 26 days ago

Meet Azitra: Fly Exclusive with CEO Francisco Salva

Azitra building multi market microbial engineering platform, CEO says

2026-07-29T18:05:54.000Z - 26 days ago

Azitra building multi market microbial engineering platform, CEO says

Azitra says Phase 1/2 ATR 04 trial remains on track for topline data this year

2026-07-29T18:05:50.000Z - 26 days ago

Azitra says Phase 1/2 ATR 04 trial remains on track for topline data this year

CEO says breadth of Azitra’s platform opens multiple attractive markets

2026-07-29T18:05:45.000Z - 26 days ago

CEO says breadth of Azitra’s platform opens multiple attractive markets

Azitra announces results from two ex vivo human skin tissue studies

2026-07-15T14:30:18.000Z - 5 weeks ago

Azitra announces results from two ex vivo human skin tissue studies

Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity

Jul 15, 2026, 10:10 AM EDT - 5 weeks ago

Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity

Azitra Slides: Corporate presentation

Jul 10, 2026, 7:00 AM EDT - 6 weeks ago

Azitra Slides: Corporate presentation

Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond

Jun 17, 2026, 8:00 AM EDT - 2 months ago

Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Jun 4, 2026, 4:05 PM EDT - 2 months ago

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Azitra Proxy statement: Proxy filing

Jun 4, 2026, 8:00 AM EDT - 2 months ago

Azitra Proxy statement: Proxy filing

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

May 27, 2026, 4:30 PM EDT - 3 months ago

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

Azitra Proxy statement: Proxy filing

May 27, 2026, 8:00 AM EDT - 3 months ago

Azitra Proxy statement: Proxy filing

Azitra files to sell 255.7M shares of common stock for holders

2026-05-21T21:00:49.000Z - 3 months ago

Azitra files to sell 255.7M shares of common stock for holders

Azitra Registration statement: Registration filing

May 21, 2026, 8:00 AM EDT - 3 months ago

Azitra Registration statement: Registration filing

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

May 13, 2026, 8:30 AM EDT - 3 months ago

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

Azitra Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 3 months ago

Azitra Quarterly report: Q1 2026

Azitra Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 3 months ago

Azitra Earnings release: Q1 2026

Azitra Proxy statement: Proxy filing

May 8, 2026, 8:00 AM EDT - 3 months ago

Azitra Proxy statement: Proxy filing

Azitra granted new U.S. patent protecting ATR-12 program

2026-05-07T06:25:51.000Z - 3 months ago

Azitra granted new U.S. patent protecting ATR-12 program

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

May 6, 2026, 8:00 AM EDT - 3 months ago

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Apr 28, 2026, 8:02 AM EDT - 4 months ago

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Azitra Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Azitra Proxy statement: Proxy filing

Why Is Azitra Inc Stock (AZTR) Up Today?

2026-03-21T00:36:00.000Z - 5 months ago

Why Is Azitra Inc Stock (AZTR) Up Today?

Azitra Inc trading resumes

2026-03-19T17:45:16.000Z - 5 months ago

Azitra Inc trading resumes

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Mar 19, 2026, 1:13 PM EDT - 5 months ago

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra Inc trading halted, news pending

2026-03-19T16:25:35.000Z - 5 months ago

Azitra Inc trading halted, news pending

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Mar 13, 2026, 5:15 PM EDT - 5 months ago

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Mar 5, 2026, 4:30 PM EST - 6 months ago

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Azitra Proxy statement: Proxy filing

Mar 5, 2026, 7:00 AM EST - 6 months ago

Azitra Proxy statement: Proxy filing

Azitra Slides: Corporate presentation

Mar 2, 2026, 7:00 AM EST - 6 months ago

Azitra Slides: Corporate presentation

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Feb 27, 2026, 5:30 PM EST - 6 months ago

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Azitra Annual report: Q4 2025

Feb 27, 2026, 7:00 AM EST - 6 months ago

Azitra Annual report: Q4 2025

Azitra Earnings release: Q4 2025

Feb 27, 2026, 7:00 AM EST - 6 months ago

Azitra Earnings release: Q4 2025

Azitra adds MD Anderson Cancer Center as site for Phase 1/2 skin rash trial

2026-02-24T13:12:53.000Z - 6 months ago

Azitra adds MD Anderson Cancer Center as site for Phase 1/2 skin rash trial

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Feb 24, 2026, 8:00 AM EST - 6 months ago

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Azitra, Inc. to Present at BIO Investment & Growth Summit

Feb 19, 2026, 8:00 AM EST - 6 months ago

Azitra, Inc. to Present at BIO Investment & Growth Summit

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Feb 6, 2026, 4:15 PM EST - 7 months ago

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Azitra Proxy statement: Proxy filing

Feb 6, 2026, 7:00 AM EST - 7 months ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 8 months ago

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Azitra Proxy statement: Proxy filing

Jan 2, 2026, 7:00 AM EST - 8 months ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Dec 23, 2025, 7:00 AM EST - 8 months ago

Azitra Proxy statement: Proxy filing

Azitra says NYSE American approves compliance plan

2025-12-17T21:16:09.000Z - 8 months ago

Azitra says NYSE American approves compliance plan

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Dec 17, 2025, 4:10 PM EST - 8 months ago

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Azitra files to sell 38.9M shares of common stock for holders

2025-12-10T21:16:02.000Z - 9 months ago

Azitra files to sell 38.9M shares of common stock for holders

Azitra Registration statement: Registration filing

Dec 10, 2025, 7:00 AM EST - 9 months ago

Azitra Registration statement: Registration filing

Azitra prices 4.69M share private placement at 32c per share

2025-11-24T14:20:36.000Z - 9 months ago

Azitra prices 4.69M share private placement at 32c per share

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Nov 24, 2025, 9:00 AM EST - 9 months ago

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Azitra Slides: Corporate presentation

Nov 13, 2025, 7:00 AM EST - 10 months ago

Azitra Slides: Corporate presentation

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Nov 12, 2025, 5:15 PM EST - 10 months ago

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Azitra Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Azitra Quarterly report: Q3 2025

Azitra Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Azitra Earnings release: Q3 2025

Azitra says report of $44M registered direct offering is false

2025-11-07T11:10:47.000Z - 10 months ago

Azitra says report of $44M registered direct offering is false

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Nov 7, 2025, 6:00 AM EST - 10 months ago

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Azitra to present preclinical progress for its ATR-01 program

2025-10-20T12:10:25.000Z - 11 months ago

Azitra to present preclinical progress for its ATR-01 program

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Oct 20, 2025, 8:02 AM EDT - 11 months ago

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Azitra receives noncompliance notification from NYSE

2025-10-03T20:55:06.000Z - 11 months ago

Azitra receives noncompliance notification from NYSE

Azitra Receives Notice of Non-Compliance from NYSE American

Oct 3, 2025, 4:45 PM EDT - 11 months ago

Azitra Receives Notice of Non-Compliance from NYSE American

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 8:10 AM EDT - 1 year ago

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Azitra Registration statement: Registration filing

Aug 29, 2025, 8:00 AM EDT - 1 year ago

Azitra Registration statement: Registration filing

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 27, 2025, 8:10 AM EDT - 1 year ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 5:00 PM EDT - 1 year ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Azitra, Inc. Announces Reverse Stock Split

Aug 11, 2025, 4:15 PM EDT - 1 year ago

Azitra, Inc. Announces Reverse Stock Split

Azitra Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Azitra Quarterly report: Q2 2025

Azitra Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 1 year ago

Azitra Earnings release: Q2 2025

Azitra Registration statement: Registration filing

Jul 18, 2025, 8:00 AM EDT - 1 year ago

Azitra Registration statement: Registration filing

Azitra Proxy statement: Proxy filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 1 year ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra Proxy statement: Proxy filing

May 29, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra Proxy statement: Proxy filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 1 year ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra Quarterly report: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Azitra Quarterly report: Q1 2025

Azitra Earnings release: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Azitra Earnings release: Q1 2025

Azitra Registration statement: Registration filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Azitra Registration statement: Registration filing

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 1 year ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 1 year ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Annual report: Q4 2024

Feb 24, 2025, 7:00 AM EST - 1 year ago

Azitra Annual report: Q4 2024

Azitra Earnings release: Q4 2024

Feb 24, 2025, 7:00 AM EST - 1 year ago

Azitra Earnings release: Q4 2024

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 1 year ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 1 year ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 1 year ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 1 year ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra Proxy statement: Proxy filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Jan 3, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 1 year ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Azitra Quarterly report: Q3 2024

Azitra Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Azitra Earnings release: Q3 2024

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 1 year ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 2 years ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra Proxy statement: Proxy filing

Oct 9, 2024, 8:00 AM EDT - 2 years ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 2 years ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 2 years ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 2 years ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 2 years ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 2 years ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 2 years ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

cheapostock
cheapostock Aug. 21 at 4:42 PM
next week watchlist, boring friday but fishing needs patience!!! $PFSA $ELAB $AZTR $LIMN $VBIO 🫡
0 · Reply
Stock_Catcher
Stock_Catcher Aug. 21 at 12:04 PM
$AZTR Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
0 · Reply
TheOne_24
TheOne_24 Aug. 21 at 6:05 AM
$AZTR $AIM $YYAI $CXAI $SMTK AZTR 🚀 BULLISH THESIS Biotech + AI-driven discovery + precision dermatology/cosmetics. Multiple catalysts across ATR-04, ATR-12, ATR-01 & ATR-COSF, including clinical data and human-skin results. 💥 AI + peptide/protein platform + multiple shots on goal = high-upside catalyst setup. 🔥 High risk microcap, but the pipeline + AI angle make AZTR one to watch.
0 · Reply
PURPLEBOY44
PURPLEBOY44 Aug. 19 at 7:57 PM
$AZTR i’ve been around for a little bit +20 years trading this little company might become a buyout candidate. I’m basing it on the news that Moderna just put out. Just my opinion though. Be careful with this one, but I got a feeling. 
0 · Reply
cheapostock
cheapostock Aug. 19 at 2:39 PM
$PFSA $LIMN $AZTR
0 · Reply
cheapostock
cheapostock Aug. 19 at 2:38 PM
$PFSA congrats to bull... move your profit to $AZTR
0 · Reply
cheapostock
cheapostock Aug. 19 at 1:29 PM
$AZTR add low and slow on this....
0 · Reply
cheapostock
cheapostock Aug. 18 at 7:56 PM
$AZTR seems real
0 · Reply
Omarzaid
Omarzaid Aug. 13 at 12:42 AM
$AZTR https://ir.azitrainc.com/news-releases/news-release-details/azitra-inc-announces-q2-2026-results-and-provides-business
0 · Reply
HumblKing
HumblKing Aug. 11 at 8:07 PM
$AZTR patent news
0 · Reply
Schizoo
Schizoo Aug. 10 at 2:20 PM
$AZTR swing
0 · Reply
Schizoo
Schizoo Aug. 6 at 3:54 PM
$AZTR 💯
0 · Reply
Schizoo
Schizoo Aug. 5 at 8:43 PM
$AZTR uptrend.. hold.
0 · Reply
Schizoo
Schizoo Aug. 4 at 3:13 PM
$AZTR 🤌😘🤷‍♂️
0 · Reply
Schizoo
Schizoo Aug. 3 at 2:04 PM
$AZTR in for a swing.
0 · Reply
dln101
dln101 Jul. 31 at 6:47 PM
$MGRX which bio penny gonna be next to 🚀 $AZTR or $CLGN 🤔💪📈
0 · Reply
theflynews
theflynews Jul. 29 at 6:21 PM
Meet Azitra: Fly Exclusive with CEO Francisco Salva - $AZTR - https://thefly.com/AZTR
0 · Reply
Aleexandder
Aleexandder Jul. 25 at 12:17 AM
$AZTR Develops genetically engineered skin bacteria and protein-based therapies designed to treat dermatologic diseases. Its approach aims to use the skin microbiome as a therapeutic delivery platform!!
0 · Reply
AVCTQ
AVCTQ Jul. 24 at 9:09 AM
$AZTR great opportunity with $RECT Read and take a look.
0 · Reply
MikiTrader
MikiTrader Jul. 18 at 5:55 PM
$AZTR I told you it was heavy much more than you think
0 · Reply
StockHolms
StockHolms Jul. 17 at 4:46 PM
$AZTR Holding up nicely for a Friday …. Let’s get some positive news. Send it !!
0 · Reply
BigGreenCandle
BigGreenCandle Jul. 17 at 4:05 PM
$AZTR Nano Cap with Institutional ownership and adding. What's the deal here? Any split coming?
0 · Reply